RxDoctor Payments Data

Charles Williams, MD

Family Medicine · Winter Park, FLNPI 1518922822

Payments from drug & device makers

$1,568in general payments, 2019–2025

Across 71 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amarin Pharma, Inc.$470
  • AstraZeneca$389
  • Pfizer$231
  • Exact Sciences$101
  • GSK$71
  • Merck$62
  • plus $244 from 9 others

What the payments were for

  • Food & beverage$1,568100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,568 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$168,138
Medicare patients
363
Services billed
3,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$54,815
JanuviaSitagliptin Phosphate27$35,601
JardianceEmpagliflozin21$17,735
Repatha SureclickEvolocumab18$9,624
VascepaIcosapent Ethyl14$6,139
SynthroidLevothyroxine Sodium31$2,537
Pravastatin Sodium230$2,098
Rasagiline Mesylate12$2,068
Colesevelam Hcl11$1,810
ValacyclovirValacyclovir Hcl28$1,750
Metoprolol Succinate106$1,393
Rosuvastatin Calcium95$1,261
Amlodipine Besylate286$1,233
Losartan Potassium179$1,215
Glipizide17$1,210

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$231$54,81546 claims
MerckJanuvia$62$35,60127 claims
AbbVieSynthroid$22$2,53731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Winter Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →